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ABSTRACT 
Effects of Continuous Treatment with Gonadotropin-releasing Hormone during the 
Anovulatory Season on Gonadotropin Secretion, Follicular Dynamics and Ovulation in 
the Mare. 
(December 2004) 
Stephanie Morton, B.S., McNeese State University 
Chair of Advisory Committee:  Dr. Gary L. Williams 
Objectives were to determine if low-dose, continuous infusion of GnRH from 
Fall to Spring, would prevent seasonal anovulation in mares. Twenty Quarter Horse 
mares, ages 18 mo to 24 yrs, were stratified by age and body condition score and 
assigned randomly to either a saline control (n = 9) or GnRH (n = 11) treatment group.  
Treatments were instituted between September 23 and October 9, 2002.  Gonadotropin-
releasing hormone was delivered in 0.9% physiological saline via Alzet osmotic 
minipumps (Model 2004) placed sc at the base of the neck, with Silastic sham pumps 
placed in control mares. Pumps were inserted on day 3 following ovulation or during the 
follicular phase if ovulation had not occurred.  Delivery rate of GnRH was 2.5 ug/h (60 
ug/d) for the first 60 d, followed by 5.0 ug/h (120 ug/d) thereafter, with all pumps 
replaced every 30 d. By December 1, all mares had become anovulatory and remained 
anovulatory until February. Mean serum concentrations of LH were not affected by 
treatment in anovulatory mares.  In contrast, control mares that exhibited ovulatory 
cycles after treatment onset had higher (P < 0.05) mean concentrations of LH during all 
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phases of the estrous cycle except diestrus.  Mean serum concentrations of FSH were not 
affected by treatment, but were lower (P < 0.05) from November though January relative 
to all other months in anovulatory mares. Interovulatory intervals in mares that cycled 
temporarily did not differ between groups.  Ovulatory control mares had slightly larger 
(P < 0.10) follicles overall than GnRH-treated mares; however, ovulatory follicle 
diameters for control and GnRH-treated mares did not differ.  Ovulatory control mares 
had higher (P < 0.10) mean concentrations of progesterone during metestrus and late 
diestrus. In a subgroup of control (n =5) and GnRH-treated (n = 5) mares, total 
releasable pools of LH in response to 1 mg GnRH did not differ between groups.  
Ovulation resumed in 3 control and 3 GnRH-treated mares by March 30.  Results 
indicate that continuous infusion of native GnRH at the doses employed herein is not 
sufficient to maintain ovulatory cycles during the anovulatory season.  
 
 
 
 
 
 
 
 
 
 
  
v
ACKNOWLEDGEMENTS 
 I would like to express my sincere gratitude to Dr. Gary L. Williams for his guidance 
and patience throughout my studies.  His assistance with experiments and writing of this 
thesis were invaluable.  Additionally, I would like to thank the members of the advisory 
committee, Dr. Paul Harms and Dr. Katrin Hinrichs, for their constructive participation 
during my studies. 
 Special thanks are extended to the employees of the Texas Agricultural Experiment 
Station, Beeville.  Their hard work, long hours and dedication to my experiment is 
immensely appreciated.  Additionally, I would like to thank Lloyd Vaughn and Flying V 
Quarter Horses for their cooperation and generosity in loaning twenty mares for this 
experiment.   
 Heartfelt appreciation is expressed to my parents, Steven and Janice Morton, for 
their unconditional support.  Their encouragement and faith in my abilities gave me the 
will and fortitude to continually move forward and complete this degree.  I have an 
undying admiration for their accomplishments in life and gather great strength from their 
example. 
 Finally, I thank Jared Collins, without whom this work would not have been 
completed.  I value his kindness, patience and strength of character, as they were 
frequently tested.  Additionally, I would like to thank him for his selflessness and 
encouragement throughout our many years together and as I continue to pursue my 
educational goals.     
 
  
vi
TABLE OF CONTENTS 
              Page 
ABSTRACT ..........................................................................................................iii 
ACKNOWLEDGEMENTS ...................................................................................v 
TABLE OF CONTENTS.......................................................................................vi 
LIST OF FIGURES ...............................................................................................viii 
LIST OF TABLES.................................................................................................ix 
CHAPTER 
 I INTRODUCTION......................................................................................1 
 II LITERATURE REVIEW...........................................................................4 
   Seasonal influence on endocrine control of reproduction ......................4 
   Artificial photoperiod and control of cyclicity.......................................5 
   GnRH receptors....................................................................................6 
   Secretory patterns of GnRH influence gonadotropin release..................7 
   Administration of exogenous GnRH to enhance cyclicity .....................10 
 III PITUITARY AND OVARIAN RESPONSES OF QUARTER HORSE 
  MARES TO CONTINUOUS INFUSION OF GONADOTROPIN- 
  RELEASING HORMONE THROUGHOUT THE ANOVULATORY  
  SEASON....................................................................................................16 
   Introduction..........................................................................................16 
   Materials and methods..........................................................................17 
   Experimental animals ...........................................................................17 
   Experimental procedures ......................................................................18 
   Anterior pituitary responses to a single injection of GnRH....................19 
   Estrous behavior and ovarian morphology ............................................20 
   Hormone analyses ................................................................................20 
   Statistical analyses................................................................................21 
   Results..................................................................................................23 
   Ovarian morphology.............................................................................23 
   Hormone analyses ................................................................................27 
   Anterior pituitary responses to a single injection of GnRH....................32 
 
  
vi
CHAPTER                                                                                                              Page 
 
 IV CONCLUSIONS........................................................................................34 
    
REFERENCES ......................................................................................................40 
APPENDIX ...........................................................................................................47 
VITA.....................................................................................................................52 
 
    
         
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
viii
LIST OF FIGURES 
FIGURE          Page 
 1 Mean follicle diameter of anovulatory mares averaged over two-week 
  time periods throughout the study...............................................................25 
 2 Mean follicle diameter of mares exhibiting ovulatory cycles at the 
  beginning and/or end of the study, relative to day of the estrous cycle ........26 
 3 Mean serum concentrations of FSH in mares exhibiting ovulatory cycles  
  at the beginning and/or end of the study, relative to day of the estrous 
  cycle...........................................................................................................29 
 4 Mean serum concentrations of LH in mares exhibiting ovulatory cycles 
  at the beginning and/or end of the study, relative to day of the estrous  
  cycle...........................................................................................................29 
5 Mean serum concentrations of progesterone in mares exhibiting 
ovulatory cycles at the beginning and/or end of the study, relative to  
day of the estrous cycle ..............................................................................30 
 6 Mean serum concentrations of LH and FSH in anovulatory mares  
  throughout the 28-week experiment............................................................31 
 7 Pooled mean serum concentrations of FSH in anovulatory control and  
  GnRH-treated mares averaged over each month of the study ......................32 
 8 Mean serum concentrations of LH after a 1.0 mg iv injection of GnRH 
  in a subgroup of control (n=5) and GnRH-treated (n=5) mares ...................33 
  
   
 
 
 
 
 
 
 
 
 
 
  
ix
 
LIST OF TABLES 
TABLE          Page 
1 Mean values of ovarian morphology in control and GnRH-treated mares 
on March 3, 2003 .......................................................................................27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
1
CHAPTER I 
INTRODUCTION 
 
 Seasonal anovulation of mares is a limiting factor in controlled breeding 
programs.  Because breed organizations have established January 1 as the universal birth 
date of foals, an operational breeding season has been imposed upon the horse that does 
not coincide with its natural breeding season.  In the Northern Hemisphere, the natural 
breeding season for the mare is between April and October when days are long.  
Between the months of November and March, approximately 85% of mares will exhibit 
erratic cycles and/or cease ovulation (1).  Gestation in the mare is approximately eleven 
months, requiring breeding to begin in February to produce competitive foals with birth 
dates near January 1.  Therefore, the conflict between the universal birth date and 
seasonal anovulation of the mare burdens breeding operations, both managerially and 
economically. 
 Decreasing the period of anovulation is often required to facilitate efficient 
reproduction during the operational breeding season.  Extending day length with 
artificial lighting to achieve a total of 14-16 h of light, beginning in mid winter, results in 
earlier onset of ovulation for a majority of mares (1-3).  Although effective, the adoption 
of this practice is limited.  Therefore, mares are often brought to breeding farms still 
undergoing transition from winter anovulation into the resumption of ovulatory cycles, 
resulting in extended boarding and handling for teasing and palpation.1 This increases 
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the cost of management to the breeder and owner.  Effective and efficient methods of 
controlling seasonal anovulation are needed to minimize economic losses associated 
with failure to establish normal estrous cycles during the operational breeding season.   
 Recent efforts to control seasonal anovulation have focused on the administration 
of exogenous gonadotropin-releasing hormone (GnRH) and its analogues (GnRHa).  The 
ability of exogenous GnRH to influence ovarian cyclicity is dependent upon an adequate 
number of GnRH receptors on gonadotrophs of the anterior pituitary and the type of 
releasing hormone administered.  The mare is unique in her ability to maintain a high 
concentration of GnRH receptors during both seasonal anovulation and during 
continuous treatment with exogenous GnRH (4, 5).  Analogs of GnRH differ in their 
amino acid sequences relative to native GnRH, and these differences can either increase 
or decrease their biological activity.  Increased receptor binding affinity is an effect 
observed with most GnRHa, regardless of whether the analog acts as an agonist or 
antagonist (6).  Although several potent GnRHa have been used to stimulate 
gonadotropin secretion in anovulatory mares, ovarian responses have been highly 
variable and often disappointing.  Several studies indicate that administration of native 
GnRH at low doses administered to seasonally anovulatory mares may be successful in 
stimulating positive pituitary responses, and thus ovulation (7-10).  Collectively, these 
reports have led us to hypothesize that continuous low-dose infusion of GnRH, 
administered to cyclic mares beginning in October (Northern Hemisphere) and 
continuing through the winter, will prevent the onset of seasonal anovulation.  
Objectives of the current study were to test that hypothesis, and to determine hormonal 
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profiles, estrous behavior, interovulatory intervals, and ovarian characteristics associated 
with GnRH treatment.                                                                                
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CHAPTER II 
LITERATURE REVIEW 
 
 Seasonal influence on the endocrine control of reproduction 
The mare is a seasonally polyestrous animal whose estrous cycles are regulated 
by photoperiod.  During periods of decreasing day length, gonadotropin secretion 
declines and 70-85% of mares in the Northern Hemisphere cease ovulation (1, 11).  As 
day length increases, the mare undergoes a period of transition in which the 
hypothalamic-pituitary axis becomes reactivated and increasing amounts of 
gonadotropins are secreted (2, 5).  This transitional period is associated with erratic 
periods of estrus, which are typically infertile because of a lack of follicular 
development and ovulation (1).  The natural ovulatory season for the mare in the 
Northern Hemisphere is between April and October.  The majority of mares will cease 
ovarian activity at some point during the period from November to March. 
 Seasonal anovulation in the mare is a direct effect of day length as perceived by 
the eyes and signaled via a multineuronal pathway to the pineal gland.  Dusk, as 
perceived by the animal, is associated with a sharp increase in melatonin secretion from 
the pineal gland.  An increase in melatonin release persisting for 10 h after dusk defines 
a long night (12). Although the mechanisms are unknown, melatonin reduces 
gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus.  
Hypothalamic and pituitary contents of GnRH and luteinizing hormone (LH), 
respectively, fluctuate with season or photoperiod and are lowest during the middle of 
  
5
the anovulatory season (13).  However, content of follicle stimulating hormone (FSH) in 
the pituitary exhibits no seasonal change (5, 13).  This implies that the decrease in GnRH 
secretion reduces the synthesis of LH, but not FSH, in the seasonally anestrous mare.  In 
contrast, the ewe, which is a short-day breeder, has a positive hypothalamic and pituitary 
response to increases in melatonin (14).  Unlike the mare and ewe, cows do not typically 
experience cessation and re-establishment of cyclic ovarian activity in response to 
changes in photoperiod (14).  
Artificial photoperiod and control of cyclicity 
The universal birth date (January 1) imposed by many breed organizations has 
caused a misalignment of the operational and natural breeding season of the mare.  
Current management practices designed to control seasonal anovulation and enhance 
early onset of estrous cycles include artificial lighting programs and use of exogenous 
hormones (1, 15).  Although sheep are seasonal breeders, lighting regimens are not 
practical for this species because exposure to light must be reduced to induce cyclic 
activity.  In contrast, artificial lighting programs for horses are designed to increase day 
length in the fall and winter months prior to the breeding season.  By removing the 
stimulus for melatonin secretion, the long night, mares will exhibit increased 
gonadotropin secretion and the onset of normal estrous cycles can be hastened (1, 2).  By 
providing 14-16 h of total daylight beginning in early December, the majority of mares 
will establish normal estrous cycles near March 1 (1, 15).  Artificial light should be 
added at the end of the day, prior to dusk, postponing the sharp increase of melatonin 
and preventing the presence of melatonin 10 h after dusk (1, 12).  Artificial lighting 
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results in a measurable increase in LH pulse frequency with decreasing amplitude, 
thereby enhancing the potential for resumption of ovulation (2).  Lighting programs, 
when properly managed, effectively establish early, fertile estrous cycles in many mares 
(1).  However, many horse owners and breeders do not use lighting programs due to 
their inconvenience of application.  Therefore, alternative methods for management of 
seasonal anovulation would be well-received.   
GnRH receptors 
Reproduction in mammals is controlled via the hypothalamic-hypophyseal axis.  
The interaction between the hypothalamus and anterior pituitary is dependent upon the 
secretion of releasing hormones from the hypothalamus and the presence of their 
receptors on the pituitary.  Specifically, gonadotropin-releasing hormone receptor 
concentration and affinity are principal factors regulating the synthesis and release of LH 
and FSH from the anterior pituitary, and thus ovulation.  Castration, steroid hormone 
concentrations, and fluctuating reproductive states influence receptor number and 
affinity.  Additionally, endogenous GnRH is an important up-regulator of its own 
receptor (16).  The physiological increase in estradiol prior to the LH surge also 
enhances GnRH receptor concentration and affinity in all species studied (16).  Anterior 
pituitary receptors for GnRH are maintained in the mare in relatively high numbers 
throughout all seasons (5, 13).  Porter and Sharp (4) recently characterized GnRH 
receptor trafficking in the mare.  They observed a slow rate of receptor endocytosis 
compared to that reported for other species, as well as increased GnRH receptor binding 
in the presence of continuous GnRH infusion.  When pituitary GnRH receptor 
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concentrations were measured in cycling heifers, concentrations during estrus and the 
follicular phase were higher compared to the luteal phase of the estrous cycle (17).  Non-
cyclic and pregnant cows exhibited the lowest concentrations of GnRH receptors 
compared to other physiological states (17).  Tortenese et al. (18) has shown that 
gonadotroph cell populations are affected by season and stage of estrus in the mare.  A 
significant increase in density of gonadotrophs in the pars tuberalis occurred in cyclic 
mares during both the breeding and non-breeding seasons as compared to seasonally 
anestrous mares.  Similar studies in the ewe revealed no seasonal effects on gonadotroph 
cell populations in the pars tuberalis or pars distalis and noted a lower density of cells 
compared to the horse (19).  These studies indicate that density of gonadotroph cell 
populations may, in part, motivate the seasonal changes in gonadotropin release in the 
mare.  Additionally, when a decline in GnRH receptor concentration, affinity, and/or 
sensitization occurs, a decrease in LH release is observed in cattle (17), horses (20), 
sheep (21), and rodents (16).  The limited availability of LH for release is considered the 
primary cause of anovulation in the mare.   However, the ability of the equine anterior 
pituitary to maintain GnRH receptor affinity and concentration throughout the 
anovulatory season implies that exogenous GnRH can be used successfully to control 
seasonal anovulation.   
Secretory patterns of GnRH influence gonadotropin release 
Patterns of GnRH and gonadotropin secretion are highly correlated during all 
stages of the estrous cycle (14, 22-25).  In the diestrous mare, concurrent pulses of LH 
and FSH measured in the periphery are accompanied by hypothalamic release of GnRH 
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(22).  However, small pulses of gonadotropin release can be detected in venous blood of 
the intercavernous sinus between major pulses of GnRH, and contribute to the basal 
level of circulating hormone (23).  Intercavernous sinus samples collected every 30 sec 
from mares in estrus revealed a virtually continuous release of GnRH, with larger pulses 
occurring every 30-60 min (22).  The latter were accompanied by an LH and FSH pulse.  
Research conducted by Irvine and Alexander also demonstrated that about 35% of low 
amplitude pulses of GnRH are not associated with a pulse of LH or FSH (23).  A similar 
study using mares during the periovulatory period reported 9% of low amplitude GnRH 
pulses failed to initiate a pulse of LH or FSH (24).  These observations suggest that low 
amplitude pulses of GnRH may stimulate gonadotropin synthesis and/or release at low 
amplitudes, while high amplitude pulses of GnRH stimulate high amplitude pulses of LH 
and FSH.  This may explain why various GnRH treatments successfully stimulate the 
release of LH and FSH in sufficient amounts and induce ovulation in the mare.  
However, exogenous administration of GnRH to humans, sheep, and rodents must be 
pulsatile to mimic the endogenous patterns of GnRH and to avoid receptor 
desensitization or down-regulation (25). 
Prepubertal heifers given GnRH for 72 h in a pulsatile (2.5 ug/2 h) or continuous 
(1.25 ug/h) pattern responded initially with an increase in serum concentrations of LH 
and estradiol (26).  However, continuous infusion ultimately resulted in a delay in 
puberty compared to pulsatile infusion.  The delay in puberty was a result of receptor 
down-regulation or desensitization of the pituitary to endogenous GnRH and loss of LH 
pulsatility (27).  Gong et al. (28) reported an initial increase in serum LH and FSH 
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following osmotic pump infusion of buserelin, a GnRH analogue (GnRHa), for 48 d.  
However, circulating concentrations returned to baseline by day 8 of treatment and 
remained low until 4-5 d after pump removal.  The same laboratory produced similar 
results when 5 or 10 ug of buserelin were administered i.m. twice daily for 3 weeks (29).  
After an initial increase in serum concentrations of LH, the gonadotropin returned to 
basal levels, follicles failed to develop beyond 9 mm, and both the LH surge and 
ovulation failed to occur.  These and other similar data have led to the experimental use 
of GnRH and GnRHa as management tools for suppressing reproductive cyclicity in 
cattle (30).   
A comparative study involving pony mares and ewes provided stark contrasts of 
responses to pulsatile and continuous infusion of GnRH.  Pony mares responded to all 
GnRH treatments with increased plasma concentrations of LH (25).  In contrast, ewes 
treated continuously with GnRH (2.5 and 25 ug/h) had reduced concentrations of LH 
and reduced pulse frequency, indicative of receptor down-regulation.  However, ewes 
receiving 250 ng/h in a pulsatile fashion exhibited patterns of LH secretion that did not 
differ from controls (25).  In another study, pulsatile infusion of GnRH (250 ng/2h) to 
nutritionally restricted ewes was successful in restoring gonadotropin synthesis and 
secretion to levels similar to that of normally-fed controls (31).  In congenitally GnRH-
deficient, hypogonadal mice, chronic pulsatile infusion of GnRH stimulates receptor up-
regulation and rapid increases in synthesis and release of FSH and LH, with the rate 
slower for LH than FSH (16).  A study in amenorrheic women compared ovarian 
responses to pulsatile and continuous infusion of GnRH (32).  All women ovulated 
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during the pulsatile regimen and had significantly increased serum concentrations of 
FSH, LH and estradiol compared to controls.  However, continuous infusion produced 
no ovulations and no significant rise in biologically active gonadotropin or serum 
concentration of estradiol.    These observations demonstrate the importance of pulsatile 
infusion of GnRH in humans, sheep and rodents for producing a positive gonadotropic 
response.  However, cattle exhibit greater sensitivities to GnRH and GnRHa treatments, 
resulting in down regulation of receptors and loss of LH secretory patterns sufficient to 
induce cyclicity or ovulation.   Collectively, the published literature supports the idea 
that the mare is unique in her ability to respond to long-term, continuous treatment with 
GnRH.    
Administration of exogenous GnRH to enhance cyclicity 
Although mechanisms for positive responses to long-term exposure of exogenous 
GnRH are present in the mare, type of GnRH preparation, dose, and method of 
administration have proven to be sources of significant variation relative to expected 
responses.  Multiple studies utilizing the GnRHa, goserelin, in seasonally anovulatory 
mares during February (August, Southern Hemisphere) provided variable results.  
Continuous infusion using a sc implant that delivered 60 ug/d or greater of goserelin for 
28 d (7, 32, 33) resulted in mares exhibiting variable LH, FSH and ovulatory patterns.  
Fitzgerald et al. (33) observed 61% of mares receiving 60 ug/d of goserelin ovulating in 
year 1, but only 11% ovulated in response to the same dose in year 2.  Frequency of 
ovulation decreased in mares receiving higher concentrations of goserelin overall, with 
variation between years for identical treatments.  Turner and Irvine (7) reported that 
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continuous infusion of 120 ug/d of goserelin resulted in 54% of mares ovulating between 
days 5 and 19 of treatment and developing a functional corpus luteum.  However, 18% 
of mares ovulated between days 19 and 27 and failed to develop a functional corpus 
luteum.  The remaining mares failed to ovulate during treatment, but all ovulated within 
3 weeks after the end of treatment (7).  Concentrations of LH and FSH during the 
periovulatory period exhibited normal patterns for mares that ovulated and developed a 
corpus luteum.  Mares which ovulated but failed to establish a corpus luteum exhibited 
concurrent LH and FSH peaks during the peri-ovulatory period (7).  Mumford et al. (34) 
reported ovulation in only 10% of mares receiving continuous infusion of 60 ug/d of 
goserelin.  Concentrations of LH peaked at day 12 of treatment and increased with 
increasing doses of goserelin.  Those mares with follicles < 15 mm in diameter at the 
start of treatment ovulated less frequently than those with follicles 16 to 20 mm in 
diameter regardless of treatment group.  Importantly, of the mares that ovulated in all 
treatment groups, the mean interval to the next ovulation was 71 d (34).  All reports have 
indicated an inconsistency in repeatability of treatment responses, with stage of follicular 
development at the start of treatment playing an important role in their success.  
Additionally, the extended interovulatory interval reported by Mumford et al. (34) 
suggests down-regulation of GnRH receptors in the pituitary of mares receiving 
goserelin, resulting in decreased gonadotropin secretion and failure of ovulation.   
A comparison of pulsatile GnRH with GnRHa (buserelin) given twice daily in 
anestrous mares from January to March resulted in GnRH-treated mares ovulating 
(11/14) during all months (8).  Mares treated with GnRH were given a 10 ug pulse every 
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hour administered over a 1-min period using a peristaltic pump, with GnRHa-treated 
mares given one 10 ug injection twice daily.  The GnRHa was not effective in inducing 
ovulation during January.  All mares that ovulated in January and February returned to 
anestrus when GnRH or GnRHa support was removed (8).  Additionally, the GnRH-
treated group had higher concentrations of LH, regardless of the occurrence of ovulation, 
than did the GnRHa-treated group.  Failure of GnRHa-treated mares to ovulate in 
January indicates an inadequate degree of pituitary stimulation due to dose or method of 
administration.  In this study, twice daily injections may have been insufficient to 
produce a physiological pattern of LH secretion and concentration effective for inducing 
ovulation in deeply anestrous mares.  Alternatively, the GnRHa dose may have been too 
high, resulting in GnRH receptor down-regulation.  However, the pulsatile 
administration of GnRH provided adequate pituitary stimulation regardless of 
photoperiod or stage of anestrous.   
Due to extreme differences in potency and action on GnRH receptors between 
native GnRH and GnRH analogues, several studies have focused on the use of native 
GnRH to treat seasonally anovulatory mares.    Methods of administering native GnRH 
have also been compared using pulsatile iv (9, 10), continuous iv (10), or continuous sc 
infusion (35, 36).   Johnson reported that administration of GnRH by pulsatile infusion at 
dosages of 2 and 20 ug/h resulted in ovulation within 5.7 and 12 d, respectively (9).  
However, the occurrence of multiple ovulations was high, ranging from 1-6 in small 
groups (n=7) of mares receiving 20 ug/h of GnRH.  A similar experiment from the same 
laboratory compared pulsatile and continuous iv infusion of GnRH at the same doses 
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(10).  Mares receiving pulsatile treatment had earliest days to ovulation and highest 
concentrations of LH on the day of ovulation compared to control and continuously 
infused mares.  However, these mares had smaller follicles and an increased incidence of 
multiple ovulations compared to mares receiving continuous infusion of GnRH at 2 and 
20 ug/h (10).  Mares receiving continuous iv infusions of GnRH at 2 ug/h (4/4) failed to 
ovulate spontaneously within 16 days of treatment, but did ovulate after an injection of 
2,000 IU of hCG with mean follicle size of 49 mm.  Multiple studies from Australia 
have demonstrated the use of continuous infusion of GnRH in mares in seasonal 
anovulation and mares undergoing transition from seasonal anovulation into the 
breeding season.  Hormone was delivered at a rate of 45 (Group 1) or 90 (Group 2) ug/h 
via osmotic minipump for 28 d (35).  Treatment resulted in fewer days to ovulation for 
mares treated with GnRH in Group 1 (19.3 ± 1.6) and Group 2 (15.9 ± 1.5) compared to 
controls (34.2 ± 2.5).  The percentage of mares that ovulated within 35 d of onset of 
treatment was 90.5, 97.2, and 59.2% for Group 1, Group 2, and controls, respectively.  
Mean concentrations of LH were significantly higher in GnRH-treated mares compared 
to controls, but there was no difference between GnRH-treated groups (35).  Mares 
undergoing transition were treated in a similar fashion using continuous sc infusion of 
GnRH at a rate of 45 ug/h (36).  Days to ovulation were 18.6 and 54.8 d for treated and 
control mares, respectively.  Additionally, volume of the ovulatory follicle doubled 
within 7 d for treated mares, while follicles of control mares increased only slightly.  
Plasma concentrations of LH rose to ovulatory levels within 5 d of the start of treatment 
for GnRH-treated mares, whereas an increase in LH for most control mares occurred 
  
14
after day 40 (36).  These data further demonstrate the ability of low-dose, continuous 
infusion of GnRH to enhance LH synthesis and secretion and to induce ovulation in 
seasonally anovulatory and transitional mares. 
 Results of administering GnRH to ovulatory mares during the breeding season 
supports the view that exogenous, native GnRH can be used in ways that do not 
markedly interfere with endogenous patterns of LH secretion (10, 37).  Becker and 
Johnson reported that pulsatile and continuous iv infusion of GnRH at a rate of 20 ug/h 
to cyclic mares had no effect on the day of ovulation (10).  However, mares receiving 
continuous infusion beginning on day 16 of the estrous cycle did have lower serum 
concentrations of LH on the day of ovulation compared to the pulsatile and control 
groups (10). In comparison, pulsatile iv infusion did not produce elevated serum LH 
concentrations compared to controls.  These data suggest that 20 ug/h of GnRH 
administered to cyclic mares by continuous iv infusion may cause some down-regulation 
of the GnRH receptor and reduction of LH secretion without interfering with ovulation.  
However, pulsatile iv infusion at the same dose fails to stimulate the receptor and elevate 
LH concentrations in the cyclic mare.   
Recent work conducted in our laboratory demonstrated the use of continuous sc 
infusion of GnRH at a rate of 2.5 ug/h (60 ug/d) to induce follicular development in 
idiopathic and lactationally anestrous mares during the physiological breeding season 
(37).  Treatments were administered over three 14-d periods.  Period I compared GnRH-
treated mares (GnRH/GnRH) to untreated control mares (Control/GnRH).  Mares failing 
to develop a 35 mm follicle or ovulate at the end of Period I were either switched to 
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GnRH treatment (Control/GnRH) or reimplanted (GnRH/GnRH).  At the end of Period 
I, 47.8% (11/23) of GnRH-treated mares and 12.5% (2/24) of Control mares developed a 
35 mm follicle and ovulated (37).  Control mares receiving GnRH implants during 
Period II exhibited a marked increase in follicular development and ovulation.  By the 
end of Period III, the percentage of ovulations was similar for both treatment groups at 
approximately 85% (37).  Serum concentrations of LH increased for GnRH-treated 
mares.  Additionally, administration of GnRH at this low dose to cyclic mares had no 
adverse effects on cyclicity or interovulatory interval (37).  Results indicate that the 
equine pituitary can respond effectively to continuous infusion of low doses of native 
GnRH during both the anestrous and transitional periods.   
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CHAPTER III 
PITUITARY AND OVARIAN RESPONSES OF QUARTER HORSE MARES TO 
CONTINUOUS INFUSION OF GONADOTROPIN-RELEASING HORMONE 
THROUGHOUT THE ANOVULATORY SEASON 
 
Introduction 
In the Northern Hemisphere, the natural breeding season for the mare is between 
April and October when daylength is long.  Between the months of November and 
March, approximately 85% of mares will exhibit erratic cycles and/or cease ovulation 
(1).  Because most breed organizations have established January 1 as the universal birth 
date of foals, an operational breeding season has been imposed upon the horse that does 
not coincide with its natural breeding season.  Effective and efficient methods of 
controlling seasonal anovulation are needed to minimize economic losses associated 
with failure to establish normal estrous cycles during the operational breeding season.   
 Recent efforts to reduce the period of seasonal anovulation have focused on the 
administration of exogenous GnRH and its analogues (GnRHa).  The ability of 
exogenous GnRH to influence ovarian cyclicity is dependent upon an adequate number 
of GnRH receptors on gonadotrophs of the anterior pituitary and the type of releasing 
hormone administered.  The mare is unique in her ability to maintain a high 
concentration of GnRH receptors during both seasonal anovulation and during 
continuous treatment with exogenous GnRH (4, 5).  Although several potent GnRHa 
have been used to stimulate gonadotropin secretion in anovulatory mares, ovarian 
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responses have been highly variable and often disappointing.  Several studies indicate 
that low doses of native GnRH administered to seasonally anovulatory mares may be the 
most successful in stimulating positive pituitary responses, and thus ovulation (7-10).    
Collectively, these reports have led us to hypothesize that continuous low-dose infusion 
of GnRH, administered to cyclic mares beginning in October (Northern Hemisphere) 
and continuing through the winter, may have the potential to prevent the onset of 
seasonal anovulation.  Objectives of the current study were to test that hypothesis, and to 
determine hormonal profiles, estrous behavior, interovulatory intervals, and ovarian 
characteristics associated with GnRH treatment administered in this manner. 
Materials and methods 
Experimental animals 
Twenty non-pregnant Quarter Horse mares obtained in mid August 2002 were 
maintained on pasture, with free access to water and salt.  Grain (14% crude protein, 
mixed grain, soybean meal and molasses; Falls City Milling, Falls City, TX) was 
provided as needed to adjust and maintain a body condition score of 5 (good; 1-9 scale).  
All mares were stratified by age and initial body condition score, then assigned 
randomly to a 1) GnRH-treated (n=12) or 2) Control (n=10) group.  Mares ranged in age 
from 18 months to 24 years at the start of the experiment.  Transrectal ultrasonography 
was employed to examine ovarian morphology and to confirm cyclicity prior to the start 
of the experiment.  Mares were classified as cyclic upon visual confirmation of a corpus 
luteum.   Young mares were assumed to have entered puberty based on age if cyclicity 
could not be confirmed.  To aid with data collection, some estrous cycles were loosely 
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synchronized with PGF-2α during the mid-luteal phase of a cycle before the start of the 
experiment. 
Experimental procedures 
Gonadotropin-releasing hormone was delivered in 0.9% physiological saline via 
an Alzet osmotic minipump (Model 2004; Durect Corporation, Cupertino, CA).  Alzet 
pumps were incubated in 0.9% physiological saline at 37ºC for 40 h prior to 
implantation as recommended by the manufacturer.  Sham pumps were made from 
silicone tubing and filled with silicone to approximate the size of the Alzet pumps, then 
sterilized prior to surgical insertion.  Beginning September 23 and continuing through 
October 9, 2002, GnRH and sham pumps were inserted on day 3 following a 
synchronized ovulation or during the follicular phase if ovulation had not occurred.  
Pumps were inserted surgically at the base of the neck, in front of the shoulder using 
aseptic technique.  The surgical site (approximately 6 x 6 cm) was clipped free of hair, 
scrubbed with 7.5% providone-iodine scrub, and disinfected with 1.0% providone-iodine 
solution.  Three to five cc of 2% Lidocaine HCl (Vedco, St. Joesph, MO) were injected 
sc and a 1 ½ - 2 cm incision was made through the skin using a no. 10 blade.  A blunt 
surgical instrument was utilized to create a sc pocket ventral to the incision to 
accommodate the pump.  Pumps were disinfected in a 2% chlorhexide gluconate 
solution (Nolvasan) and placed under the skin below the opening of the incision.  The 
incision was closed using a non-absorbable suture (Suture Vet, Vetus Animal Health, 
Rockville Centre, NY) that was removed 7-10 days following the procedure.  Pumps 
were removed utilizing the same procedure and a new GnRH or sham pump was inserted 
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every 30 days at alternating sites on both sides of the neck until the end of the 
experiment (March 31, 2003).  During the first 60 d, GnRH-treated mares received 
GnRH (Bachem California Inc, Torrance, CA) at a rate of 2.5 ug/h (60 ug/d) followed by 
a delivery rate of 5.0 ug/h (120 ug/d) for the remainder of the experiment (approximately 
120 days).  
 Blood samples were collected via jugular venipuncture to determine circulating 
concentrations of LH, FSH, and progesterone.  When a follicle ≥ 35 mm was present or 
at the onset of estrus, whichever occurred first, blood was collected once daily until 3 
days after ovulation.  Blood samples were collected once every 2-3 days at all other 
times.  Samples were placed on ice immediately following collection, then allowed to 
clot at room temperature for 2 h.  Serum was harvested by centrifugation, divided into 
two aliquots, and stored at -20˚C until hormone analyses. 
 Anterior pituitary responses to a single intravenous injection of GnRH   
On March 5, 2003, 10 mares were selected from GnRH (n=5) and control (n=5) 
groups to determine if stores of LH in gonadotrophs had been affected by GnRH 
treatment.  To avoid the potential for induced ovulation, only mares with all follicles less 
than 25 mm were used.  Each mare was fitted with an indwelling jugular catheter (14 
GA x 83 mm, Angiocath; Becton Dickinson, Sandy, Utah) using aseptic technique on 
the morning of the experiment.  Mares were separated in pairs into small pens and 
allowed to rest for 1 h before the start of the experiment.  Blood samples (10 ml) were 
collected at -60, -30, 0, 15, 30, 45, 60, 90, 120, 180, 210, and 240 min relative to iv 
injection of GnRH (1.0 mg in 2.0 ml 0.9% physiological saline) administered via the 
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catheter.  Blood samples were dispensed into tubes containing 150 ul of solution 
containing heparin (1000 IU/ml) and 5% EDTA and placed on ice.  All jugular catheters 
were removed at the end of the 5-h experiment.   
 Estrous behavior and ovarian morphology 
Mares were teased in groups of five in a large pen adjacent to a stallion on a daily 
basis.  Teasing scores were as follows: 1) breaks down, urinates, 2) winking, intense 
interest in stallion, 3) some interest in stallion, 4) passive, 5) rejects stallion.  Palpation 
and transrectal ultrasonography (Concept/MCV, Dynamic Imaging, Livingston, 
Scotland, UK) were employed at 1-3 day intervals to assess ovarian morphology.  When 
a follicle greater than or equal to 35 mm was observed or at the onset of estrus, 
whichever occurred first, mares were examined daily by transrectal ultrasonography 
until ovulation.  Visual presence of a corpus luteum after ovulation was also confirmed 
by transrectal ultrasonography.  An intensive comparison of ovarian morphology was 
conducted on March 3, 2003; all visible follicles from all mares in the study were 
counted and measured in mm using transrectal ultrasonography.   
Hormone analyses 
  Serum concentrations of LH and FSH were determined by double antibody RIA 
for all samples collected.  A highly purified equine LH (eLH AFP-5130A) preparation 
was used for both iodinated tracer and standards. An anti-eLH antiserum (AFP-240580) 
was used at a dilution of 1:120,000, which yielded 25.8% binding at B/O. A highly 
purified equine FSH (eFSH AFP-5022B) preparation was used for both iodinated tracer 
and standards.  An anti-eFSH antiserum (AFP-2062096) was used at a dilution of 
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1:12,500, and yielded 29.4% binding at B/O.  The intraassay and interassay coefficients 
of variation (CVs) were 7.9% and 5.5% respectively for LH, and 5.8% and 2.3% 
respectively for FSH assays.  Serum progesterone was measured using a commercial 
single antibody RIA kit (Diagnostic Products Corporation, Los Angeles, CA).  When 
mares had progesterone values below 1 ng/ml and minimal follicular activity only 2 
samples per week were assayed.  The intraassay and interassay CVs for progesterone 
were 10.3% and 4.1% respectively.   
Statistical analyses  
After the experiment was conducted, data from 2 mares, 1 control (#4090) and 1 
GnRH-treated (#3025), were removed due to extreme variations in hormone levels and 
cycle characteristics.  Mare 4090 had serum concentrations of LH (range of 6.25 to 
31.70 ng/ml) greater than 2 standard deviations above the mean for all other mares for 
more than 60 days from the start of the experiment.  Serum concentrations of 
progesterone were also elevated with values above 20 ng/ml for more than 30 days and 
not declining to < 1 ng/ml until late November.  Mare 3025 (GnRH) was eliminated due 
to elevated serum concentrations of LH (range of 11.07 to 19.09 ng/ml) which were 2 
standard deviations above the mean for the first 30 days of the experiment.  This mare 
had interovulatory intervals in 5 of 8 cycles that were less than 20 days, 4 of which were 
less than 15 days.  These short interovulatory intervals were not diestrous ovulations, as 
a decline in serum progesterone to levels below 1 ng/ml occurred prior to each ovulation.  
The final number of mares used for statistical analysis in control and GnRH-treated 
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mares was 9 and 11, respectively.  However, one GnRH-treated mare died in mid 
January, but data collected until that time was included in all analyses. 
Statistical analyses of estrous cycle variables included 1) interovulatory interval, 
2) size of ovulatory follicles, and 3) number of ovulations per estrous cycle.  Mares were 
classified as ovulatory or anovulatory based on serum concentrations of progesterone 
and visual confirmation of corpora lutea by transrectal ultrasonography.  
Retrospectively, when progesterone had been less than 1 ng/ml for at least 30 days and 
no follicles greater than 30 mm had developed, mares were considered anovulatory.  
Once ovulation had resumed in an anovulatory mare, all data from that time forward was 
classified as ovulatory.    
The PROC GLM procedure of SAS was employed to conduct repeated measure 
analysis of variance on reproductive and hormonal variables.  The statistical model 
included the following sources of variation: Treatment, mare(treatment), time and 
treatment x time.  Main effects of treatment were tested using mare(treatment) as the 
error term.  When a significant F-value was obtained, means were contrasted using 
Bonferoni’s T-test.  Chi-square analysis was used for proportional data (i.e., cycling vs. 
not cycling).  Areas under the curve were calculated for the 4 h period following the 
GnRH challenge and compared using the PROC T-TEST procedure.  Numbers of small 
and medium follicles and average sizes of follicles from measurements determined on 
March 3, 2003 were contrasted using the PROC T-TEST procedure. 
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Results  
Ovarian morphology 
By the end of November, only 3/9 control and 3/11 GnRH-treated mares 
continued to exhibit ovulatory cycles.  During the months of December through 
February, all mares were anovulatory.  By the end of the experiment on March 31, 2003, 
3/9 control and 3/11 GnRH-treated mares had resumed ovulation.  Analysis of ovulation 
frequencies for each month revealed no differences between treatment groups.  Diestrous 
ovulations occurred in 2/9 control mares and 0/11 GnRH-treated mares.  One control 
mare ovulated in October and the other in November.  There were no double ovulations 
during the treatment period in either control or GnRH-treated mares.   
Interovulatory intervals for mares ovulating during the experiment ranged from 
15 to 24 d, with means of 21.0 ± 1.0 and 21.3 ± 0.7 d for control and GnRH-treated 
mares, respectively.  Mares that became anovulatory after the start of the study and 
resumed ovulation by March 31 had mean interovulatory intervals of 130.7 ± 15.2 d 
(control) and 154.3 ± 10.9 d (GnRH-treated), respectively.  Anovulatory control and 
GnRH-treated mares that failed to ovulate by March 31 (end of study), had been 
anovulatory an average of 162.7 ± 15.1 and 155.6 ± 8.5 d, respectively.    
Follicle measurements (mm) obtained throughout the experiment were compared 
for ovulatory and anovulatory mares within treatment groups.  Follicles were divided 
into three categories A) less than 21 mm, B) 21 – 34 mm and C) greater than 34 mm.  
All mares had at least one follicle less than 21 mm (category A) present throughout the 
duration of the experiment.  Follicle measurements greater than 21 mm were recorded 
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and used for analyses.  The occurrence of follicles in categories B and C did not differ 
between treatment groups over the duration of the experiment.  Additionally, there was 
no difference in occurrence of follicles in categories B and C between treatment groups 
for ovulatory and anovulatory mares throughout the experiment.  However, the mean 
follicle diameter in mares after the onset of anovulation, averaged over 14 two-week 
periods, was larger (P < 0.05) in GnRH-treated mares compared to controls during 
periods 9 and 10 (Figure 1).  Control mares had greater mean follicle diameter (P < 0.05) 
during period 11 than GnRH-treated mares.  These periods were during the months of 
January and February.  Treatment had no effect on follicle size in anovulatory mares at 
all other time periods.  Mean follicle diameter of mares exhibiting ovulatory cycles at the 
beginning and/or end of the study  was assessed within phase of the estrous cycle (Figure 
2).  Control mares had slightly larger (P < 0.10) follicles overall than GnRH-treated 
mares.  Mean follicle diameter on the day of ovulation was 40.9 ± 1.45 (control) and 
39.0 ± 0.98 mm (GnRH). 
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Figure 1: Mean follicle diameter (mm ±SEM) of anovulatory mares averaged over two-
week time periods throughout the study.  * Means differed between treatment groups (P 
< 0.05).  Treatment had no effect on follicle size at all other time periods.   
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Figure 2: Mean follicle diameters (mm ±SEM) of mares exhibiting ovulatory cycles at 
the beginning and/or end of the study, relative to day of the estrous cycle.  Control mares 
had slightly larger follicles over all periods (P < 0.10).   
 
 
On March 3, 2003, all mares were subjected to a comprehensive evaluation of all 
visible follicles using transrectal ultrasonography (Table 1).  Follicles were separated 
into the following two categories based on mean diameter (mm) of an individual follicle: 
A) less than 15 mm and B) 15-30 mm.  Average mean diameter of follicles in categories 
A and B did not differ between treatment groups, and 66.8% of all follicles were less 
than 15 mm in diameter (category A) on this date.  Neither, the total number of follicles 
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present in individual categories (A and B) nor in both categories combined differed 
between control and GnRH-treated mares.    
 
Table 1:  Mean values of ovarian morphology in control and GnRH-treated mares on 
March 3, 2003.  (Mean ± SEM) 
  No. of Follicles         No. of Follicles/mare                      Diameter 
               (mean no. ±SEM)                        (mm ±SEM) 
Treatment        A        B       A        B          A                   B 
Control (n=9)  72   36       8.0 ± 1.0  5.1 ± 1.0         11.0 ± 0.3      18.5 ± 0.6 
 
GnRH (n=10)      65        35            6.5 ± 0.8      4.9 ± 1.3           10.2 ± 0.4      17.9 ± 0.9 
Group A = follicles less than 15 mm and Group B = follicles 15 – 30 mm.   
Treatment groups did not differ for all measurements.   
 
 
Hormone analyses  
Mean serum concentrations of FSH in mares exhibiting ovulatory cycles during 
the study were not affected by treatment (Figure 3), but differed due to day of the cycle 
(P < 0.10).  Overall, FSH values during estrus were lower than during all other days of 
the estrous cycle, but did not differ (P < 0.05) from values on the day of ovulation.  
Control mares had higher (P< 0.05; Figure 4) levels of LH during all days of the estrous 
cycle except days 5-8 and 9-12.  Moreover, mean LH on the day of ovulation was 
greater (P < 0.05) in control (2.57 ± 0.4 ng/ml) than in GnRH-treated (1.32 ± 0.5 ng/ml) 
mares.  Mean serum concentrations of progesterone were also higher (P < 0.10; Figure 
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5) in control mares than GnRH-treated mares during days 1-4 and 9-12 with higher 
values observed in control mares. 
Mean serum concentrations of LH and FSH for mares which had entered 
anovulation during the study, did not differ between control and GnRH-treated mares.  
However, some differences (P < 0.05) were observed in mean concentrations of LH and 
FSH between weeks (Figure 6) and between months for FSH (Figure 7) in anovulatory 
mares.  During week 21, mean concentrations of LH were the lowest (0.09 ± 0.01 ng/ml) 
and began to rise steadily, reaching 0.3 ng/ml by the end of the experiment at week 28.  
Mean concentrations of FSH in anovulatory mares reached their lowest value (4.54 ± 0.2 
ng/ml) during week 8, and remained low until week 17, at which point concentrations 
steadily increased to greater than 6.5 ng/ml.   Mean serum concentrations of FSH in 
anovulatory mares during November, December and January were lower (P < 0.05; 
Figure 7) than those measured during September, October, February and March.  
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Figure 3:  Mean serum concentrations of FSH (ng/ml ±SEM) in mares exhibiting 
ovulatory cycles at the beginning and/or the end of the study, relative to day of the 
estrous cycle.  Means did not differ between treatments.   
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Figure 4: Mean serum concentrations of LH (ng/ml ±SEM) in mares exhibiting 
ovulatory cycles at the beginning and/or end of the study, relative to day of the estrous 
cycle. *Means differed between treatment groups (P< 0.05). 
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Figure 5: Mean serum concentrations of progesterone (ng/ml ±SEM) in mares exhibiting 
ovulatory cycles at the beginning and/or end of the study, relative to day of the estrous 
cycle.    *Means differed between treatment groups (P < 0.10).   
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Figure 6:  Mean serum concentrations of LH and FSH (ng/ml ±SEM) in anovulatory 
mares throughout the 28-week experiment.  Data represent pooled mean values from 
both treatment groups, as mean serum concentrations did not differ between groups.   
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Figure 7: Pooled mean concentrations of FSH (ng/ml ±SEM) in anovulatory control and 
GnRH-treated mares averaged over each month of the study.  a,b Means with different 
superscripts differ (P < 0.05). 
 
 
Anterior pituitary responses to a single intravenous injection of GnRH 
 Mean plasma concentrations of LH and areas under the curve following 
intravenous administration of 1.0 mg GnRH were similar for control and GnRH pump-
treated mares (Figure 8).  Maximal release of LH following injection was achieved 
within 45 min post-injection in all mares.  Peak concentrations of LH ranged from 0.41 
to 1.17 ng/ml.  Mean baseline and peak values of LH were 0.19 ± 0.07 and 0.79 ± 0.15 
ng/ml, respectively, for control and 0.23 ± 0.01 and 0.68 ± 0.14 ng/ml, respectively for 
GnRH-treated mares.  Serum concentrations did not return to baseline by the end of the 
5 h experiment.   
  a   a     a     a 
      b                    b                      b 
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Figure 8: Mean serum concentrations of LH after a 1.0 mg iv. injection of GnRH in a 
subgroup of control (n=5) and GnRH-treated (n=5) mares.  Mean baseline 
concentrations, peak concentrations, and areas under the curve did not differ between 
groups. 
 
 
 
 
 
 
 
 
   GnRH 
  
34
CHAPTER IV 
CONCLUSIONS 
 
Results of this experiment indicate that sc continuous infusion of GnRH at rates 
of 2.5 and 5.0 ug/h, are too low to provide enough pituitary stimulation for maintaining 
adequate gonadotropin secretion, follicular growth, and ovulation throughout the non-
breeding season.  Previous experiments conducted in this laboratory employed GnRH at 
a rate of 2.5 ug/h to induce follicular development in mares with idiopathic or lactational 
anovulation during the operational breeding season (37).  Approximately 85% of mares 
responded within 42 days of treatment.  Additionally, adverse effects on circulating 
gonadotropin concentrations and interovulatory intervals were not observed when the 
same treatment was applied to a limited number of cyclic mares during the breeding 
season (37).  Results of the current study imply that the doses of GnRH administered 
were inadequate to overcome the lack of photoperiodic stimulation and low endogenous 
secretion of GnRH. 
In the current study, mean concentrations of FSH and progesterone in ovulatory, 
GnRH-treated mares demonstrated a pattern of secretion typical of the estrous cycle.  
However, both groups exhibited maximal concentrations of LH before or on the day of 
ovulation rather than after ovulation as reported previously (1).  Additionally, values 
were lower than those expected during the natural breeding season when endogenous 
GnRH concentrations are higher.  McCue et al. also observed peak circulating 
concentrations of LH coinciding with the day of ovulation in seasonally anestrous mares 
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treated with GnRH (10 ug/h) or GnRHa (10 ug sc twice daily) during the anovulatory 
season (8).  Additionally, mares treated with GnRH (7.4 ± 1.5 ng/ml) had significantly 
higher (P < 0.05) concentrations of LH on the day of ovulation than GnRHa-treated (1.8 
± 0.2 ng/ml) mares (8).  During the period when most mares were anovulatory, mares 
that continued to ovulate exhibited peak concentrations of LH on the day of ovulation as 
opposed to the days following ovulation as reported previously (1).  The findings from 
this study and that of McCue et al. indicate that follicles can undergo final maturation 
and spontaneous ovulation during the winter months with much lower levels of 
circulating LH.  However, during the breeding season, ovulation most likely occurs prior 
to the presence of maximal LH concentrations due to overall higher levels of circulating 
gonadotropins and the extended half-life of equineLH.  The increased concentrations 
during the breeding season may also be accounted for by elevated concentrations of 
estrogen and enhanced pituitary responsiveness.   
Differences between months in mean concentrations of FSH in anovulatory 
mares (Figure 7) were relatively small.  However, these differences are in contrast to 
previous reports indicating that FSH release does not fluctuate in response to seasonal 
changes (1, 13).  Changes in mean FSH, while likely reflecting a seasonal influence, 
could also reflect differences between mares in their rate of transition into anovulation 
and during follicular resurgence (1).  Observed differences between weeks in mean 
concentrations of LH in anovulatory control mares were expected.  However, mean 
concentrations of LH were low for anovulatory mares in both treatment groups near the 
start of the experiment and continued to decline through the winter, reflecting limited 
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photoperiodic stimulation, reduced endogenous GnRH secretion, and inadequate 
exogenous GnRH stimulation in GnRH-treated mares.  Additionally, the gradual 
increase in mean LH in all mares after week 23 paralleled an increase in follicular 
activity typical of spring transition.   
Mean concentrations of LH for mares in this study are generally much lower than 
those reported in the literature (5, 34, 38, 39) for mares in various reproductive stages.  
The basis for this resides within our use of a highly specific, homologous RIA in the 
current study compared to the use of heterologous assays employing relatively impure 
preparations as references in earlier reported studies.  The current assays for LH and 
FSH produced values that were similar to the homologous and heterologous assays 
reported by McShan and Papkoff (1, 7, 40, 41)  
Pulses of GnRH in the mare have been reported to be secreted at low amplitudes 
in a virtually continuous manner with occasional high amplitude pulses (22-24).  Large 
pulses of GnRH are associated with concurrent pulses of LH and FSH, but low 
amplitude pulses of GnRH are not always associated with detectable increases in 
gonadotropin secretion.  Irvine and Alexander demonstrated that about 35% of low 
amplitude pulses of GnRH are not associated with a pulse of LH or FSH during the 
luteal phase (23).  A similar study in mares during the periovulatory period reported that 
9% of low amplitude GnRH pulses failed to initiate a pulse of LH or FSH (24).  In other 
species such as the cow and ewe, low amplitude pulses of GnRH stimulate gonadotropin 
synthesis and storage, while release of these stores requires higher amplitude pulses of 
GnRH (42-45).  In those species, pharmacological doses of GnRH can be used to 
  
37
estimate total releasable pools of relatively large stores of LH, even during 
anestrus/anovulation (46).  Similarly, at least one report in the mare has demonstrated 
that the magnitude of GnRH induced LH release is highly correlated with the amount of 
LH present in the pituitary, but unlike cattle and sheep, pituitary stores in the mare also 
appear to reflect circulating concentrations of LH as well (38).  In the current study, a 
1.0-mg injection of GnRH was administered in March to a selected group of control and 
GnRH pump-treated mares, to determine if continuous administration of GnRH had 
affected pituitary synthesis and storage of LH.  At this time, mean serum concentrations 
of LH were extremely low, with most values at the detection limit of the assay for a 
majority of mares.  Results indicated that continuous low-dose treatment with GnRH 
failed to adequately stimulate gonadotropin synthesis and storage, as releasable pools of 
LH were low and typical of the anovulatory season.  Therefore, our results confirm that 
releasable pools of LH are highly correlated with mean circulating concentrations in the 
mare.  However, the fact that there was no differences in anterior pituitary responses to 
GnRH between control and GnRH pump groups indicates that GnRH receptors were not 
down-regulated in GnRH pump-treated mares.  If down-regulation of GnRH receptors 
were occurring in GnRH pump-treated mares, a lower response to the GnRH challenge 
would have been likely demonstrated in these mares compared to controls. 
In contrast to anovulatory mares, some evidence emerged during the current 
study that continuous GnRH treatment had down-regulated GnRH receptor populations 
in ovulatory mares.  Mean concentrations of LH were lower in ovulatory, GnRH-treated 
mares than in control mares, during the estrous cycles that were recorded in late 
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fall/early winter and in the spring.  However, these reduced levels did not affect 
follicular development, ovulation frequency, or interovulatory intervals.  Becker and 
Johnson reported that cyclic mares receiving continuous infusion of GnRH at a rate of 
20 ug/h had lower serum concentrations of LH on the day of ovulation compared to 
mares treated with GnRH in a pulsatile manner and control groups (10).  However, mean 
concentration of LH in mares receiving pulsatile infusions of GnRH did not differ from 
controls in that study.  Additionally, mean days to ovulation did not differ between 
treatments (10).  Continuous treatment with GnRH in the current study also did not 
affect interovulatory intervals or the number of ovulations.  Thus, while some down-
regulation of the GnRH receptor may have occurred in ovulatory mares, coincident with 
a reduction in mean LH, no effects on estrous cycle events could be documented.  
Nonetheless, if the interpretation that GnRH receptor down-regulation could account for 
the lower circulating LH in GnRH-treated mares is correct, it is in contrast to other 
reports.  Porter and Sharp observed increased GnRH receptor binding in vitro in the 
presence of continuous GnRH infusion (4).  Other studies demonstrate that GnRH 
receptors are continually present throughout the physiological non-breeding season and 
do not exhibit seasonal changes in concentration (4, 13).  When acyclic mares were 
continuously infused with 25 ug/h of GnRH, pulses of LH occurred twice every 8 h (40).  
Alexander and Irvine (21) suggest that the combined endogenous and exogenous effects 
of GnRH in anovulatory mares can be raised to an effective level which stimulates a 
pulsatile secretory pattern of LH and FSH.   
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In summary, although continuous administration of GnRH at rates of 2.5 ug/h 
and 5.0 ug/h did not prevent seasonal anovulation, they also did not appear to interfere 
with follicular development and ovulation during ovulatory cycle.  Observations of 
estrous cycles beyond 60 days of treatment onset and resumption of some cycles in 
March, paralleling the natural breeding season, would support this contention.  It is 
possible that a regimen similar to the current one but at higher doses of GnRH could be 
effective in preventing seasonal anovulation.  Notwithstanding economic considerations, 
successful development of such a strategy could potentially reduce the need for other 
less effective managerial methods utilized during spring transition into the breeding 
season.  The low mean concentration of LH in ovulatory mares treated with continuous 
GnRH suggested that some interference with the hypothalamic-pituitary axis of these 
mares might be occurring.  However, GnRH receptor down-regulation as a basis of this 
phenomenon is not supported by other reported studies.    
 
 
 
 
 
 
 
 
 
  
40
REFERENCES 
 
1. Ginther OJ.  Reproductive Biology of the Mare; Basic and Applied Aspects, Cross 
Plains, WI: Equiservices, 1992, pp. 105-172, 233-290. 
2.   Fitzgerald BP, Affleck KJ, Barrows SP, Murdoch WL, Barker KB and Loy RG.  
Changes in LH pulse frequency and amplitude in intact mares during the transition into 
the breeding season.  J Reprod Fert 1987;79:485-491. 
3.  Malinowski K, Johnson AL and Scanes CG.  Effects of interrupted photoperiods on 
the induction of ovulation in anestrous mares.  J Anim Sci 1985;61:951-955. 
4.   Porter MB and Sharp DC.  Gonadotropin-releasing hormone receptor trafficking may 
explain the relative resistance to pituitary desensitization in mares.  Theriogenology 
2002;58:523-526 (abstr.). 
5.   Silvia PJ, Squires EL and Nett TM.  Changes in the hypothalamic-hypophyseal axis 
of mares associated with seasonal reproductive recrudescence. Biol  Reprod 
1986;35:897-905. 
6.   Loumaye E, Naor Z and Catt KJ.  Binding affinity and biological activity of 
gonadotropin-releasing hormone agonists in isolated pituitary cells. Endocrinology 
1982;111:730-736. 
7. Turner JE and Irvine CHG.  The effect of various gonadotropin-releasing hormone 
regimens on gonadotrophins, follicular growth and ovulation in deeply anestrous mares.  
J Reprod Fert 1991;44:213-255 (suppl.). 
  
41
8. McCue PM, Troedsson MHT, Liu IKM, Stabenfeldt GH, Hughes JP and Lasley BL.  
Follicular and endocrine responses of anoestrous mares to administration of native 
GnRH or a GnRH agonist.  J Reprod Fert 1991;44:227-223 (suppl.). 
9. Johnson AL.  Gonadotropin-releasing hormone treatment induces follicular growth 
and ovulation in seasonally anestrous mares.  Biol Reprod 1987;36:1199-1206. 
10. Becker SE and Johnson AL.  Effects of gonadotropin-releasing hormone infused in a 
pulsatile or continuous fashion on serum gonadotropin concentrations and  ovulation in 
the mare.  J Anim Sci 1992;70:1208-1215. 
11. Irvine CHG, Alexander SL and McKinnon AO.  Reproductive hormone profiles in 
mares during the autumn transition as determined by collection of jugular blood at 6 h 
intervals throughout ovulatory and anovulatory cycles.  J Reprod Fert 2000;118:101-
109. 
12. Palmer E and Guillaume D.  Photoperiodism in the equine species – what is a long 
night?  Anim Reprod Sci 1992;28:31-38. 
13. Hart PJ, Squires EL, Imel KJ and Nett TM.  Seasonal variation in hypothalamic 
content of gonadotropin-releasing hormone (GnRH), pituitary receptors for GnRH, and 
pituitary content of luteinizing hormone and follicle-stimulating hormone in the mare.  
Biol Reprod 1984;30:1055-1062. 
14. Senger PL. Pathways to Pregnancy and Parturition, Pullman, WA: Current 
Conceptions, Inc., 1999, pp. 116-129. 
  
42
15. Blanchard TJ, Varner DD and Schumacher J.  Manipulation of Estrus in the Mare. 
In: Manuel of Equine Reproduction,  Pratt PW, Merchant T, Roseman H (eds), St. Louis, 
MO: Mosby Inc., 1998, pp. 15-24. 
16. Clayton RN.  Gonadotropin-releasing hormone: its actions and receptors.  J 
Endocrinology 1984;120:11-19. 
17. Schoenemann HM, Brown JL and Reeves JJ.  LHRH receptor, LH and FSH 
concentration in anterior pituitaries of cycling, noncycling, and early pregnant heifers.  J 
Anim Sci 1985;60:532-536. 
18. Tortonese DJ, Gregory SJ, Eagle RC, Sneddon CL, Young CL and Townsend J.  The 
equine hypophysis: a gland for all seasons.  Reprod Fertil Dev 2001;13:591-597. 
19. Skinner DC and Robinson JE.  The pars tuberalis of the ewe: no effect of season or 
ovariectomy on the distribution, density or presence of immunoreactive cells.  Cell 
Tissue Res 1996;284:117-123. 
20. Watson ED, Pederson HG, Thomson SRM and Fraser HM.  Control of follicular 
development and luteal function in the mare: effects of a GnRH antagonist.   
Theriogenology 2000;54:599-609. 
21. Wise ME, Nieman D, Stewart J and Nett TM.  Effect of number of receptors for 
gonadotropin-releasing hormone on the release of luteinizing hormone.  Biol Reprod 
1984;31:1007-1013. 
22. Alexander SL and Irvine CHG.  GnRH secretion in the mare.  Anim Reprod Sci 
1996;42:173-180. 
  
43
23. Irvine CHG and Alexander SL.  Secretory patterns and rates of gonadotropin-
releasing hormone, follicle stimulating hormone, and luteinizing hormone revealed by 
intensive sampling of pituitary venous blood in the luteal phase mare.  Endocrinology 
1993;132:212-218. 
24. Alexander SL and Irvine CHG.  Secretion rates and short-term patterns of 
gonadotrophin-releasing hormone, FSH and LH throughout the periovulatory period in 
the mare.  J Endocrinol 1987;114:351-362. 
25. Porter MB, Cleaver BD, Peltier M, Robinson G, Thatcher WW and Sharp DC.  
Comparative study between pony mares and ewes evaluating gonadotrophic response to 
administration of gonadotropin-releasing hormone.  J Reprod Fert 1997;110:219-229. 
26. Skaggs CL, Able BV and Stevenson JS.  Pulsatile or continuous infusion of 
luteinizing hormone-releasing hormone and hormonal concentrations in prepubertal beef 
heifers.  J Anim Sci 1986;62:1034-1048. 
27. D’Occhio MJ, Fordyce G, Whyte TR, Aspden WJ and Trigg TE.  Reproductive 
responses of cattle to GnRH agonists.  Anim Reprod Sci 2000;60-61:433-442. 
28. Gong JG, Campbell BK, Bramley TA, Gutierrez CG, Peters AR and Webb R.  
Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, 
and ovarian follicle development in heifers continuously infused with a gonadotropin-
releasing hormone agonist.  Biol Reprod 1996;55:68-74. 
  
44
29. Gong JG, Bramley TA, Gutierrez CG, Peters AR and Webb R.  Effects of chronic 
treatment with gonadotrophin-releasing hormone agonist on peripheral concentrations of 
FSH and LH, and ovarian function in heifers.  J Reprod Fert 1995;105:263-270. 
30. D’Occhio MJ, Fordyce G, Whyte TR, Jubb TF, Fitzpatrick LA, Cooper NJ, Aspden 
WJ, Bolam MJ and Trigg TE.  Use of GnRH agonist implants for long-term suppression 
of fertility in extensively managed heifers and cows.  Anim Reprod Sci 2002;74:151-
162. 
31. Kile JP, Alexander BM, Moss GE, Hallford DM and Nett TM.  Gonadotropin-
releasing hormone overrides the negative effect of reduced dietary energy on 
gonadotropin synthesis and secretion in ewes.  Endocrinology 1991;128:843-849. 
32. Southworth MB, Matsumoto AM, Gross KM, Soules MR and Bremner WJ.  The 
importance of signal pattern in the transmission of endocrine information: pituitary 
gonadotropin responses to continuous and pulsatile gonadotropin-releasing hormone.  J 
Clin Endocrinol Metab 1991;72:1286-1289. 
33.  Fitzgerald BP, Meyer SL, Affleck KJ and Silvia PJ.  Effect of constant 
administration of a gonadotropin-releasing hormone agonist on reproductive activity in 
mares: Induction of ovulation during seasonal anestrus.  Am J Vet Res 1993;54:1735- 
1745. 
34. Mumford EL, Squires EL, Peterson KD, Nett TM and Jasko DJ.  Effect of various 
doses of gonadotropin-releasing hormone analogue on induction of ovulation in 
anestrous mares.  J Anim Sci 1994;72:178-183. 
  
45
35. Ainsworth CGV and Hyland JH.  Continuous infusion of gonadotropin-releasing 
hormone (GnRH) advances the onset of oestrous cycles in Thoroughbred mares on 
Australian studfarms.  J Reprod Fert 1991;44:235-240 (suppl.). 
36. Hyland JH and Jeffcott LB.  Control of transitional anestrus in mares by infusion of 
gonadotropin releasing hormone.  Theriogenology 1988;29:1383-1391. 
37. Williams GL, Amstalden M, Garcia MR, Williams SM, Ward J, Blodgett GP and 
Quirk KS.  Control of lactational and idiopathic anovulation in mares with low-dose, 
native GnRH: Anterior pituitary and ovarian responses to continuous sc infusion.  Biol 
Reprod 2000;62:226 (abstr., suppl.). 
38. Silvia PJ, Squires EL and Nett TM.  Pituitary responsiveness of mares challenged  
with GnRH at various stages of the transition into the breeding season.  J Anim Sci 
1987;64:790-796. 
39. Nett TM, Holtan DW and Estergreen VL.  Levels of LH, prolactin and oestrogens in 
the serum of post-partum mares.  J Reprod Fert 1975;23:201-206 (suppl.). 
40. Hyland JH, Wright PJ, Clarke IJ, Carson RS, Langsford DA and Jeffcott LB. 
Infusion of gonadotropin-releasing hormone (GnRH) induces ovulation and fertile 
oestrous in mares during seasonal anoestrus.  J Reprod Fert 1987;35:211-220 (suppl.). 
41. Landefeld TD and McShan WH.  Equine luteinizing hormone and its subunits, 
isolation and physiochemical properties.  Biochemistry 1974;13:1389-1393.  
  
46
42. Nett TM, Crowder ME and Wise ME.  Role of estradiol in inducing an ovulatory-
like surge of luteinizing hormone in sheep.  Biol Reprod 1984;30:1208-1215. 
43. Levine JE, Pau KF, Ramirez VD and Jackson GL.  Simultaneous measurement of 
luteinizing hormone-releasing hormone and luteinizing hormone released in 
unanesthetized, ovariectomized sheep.  Endocrinology 1982;111:1449-1455. 
44. Clarke IJ and Cummins JT.  The temporal relationship between gonadotropin 
releasing hormone (GnRH) and luteinizing hormone (LH) secretion in ovariectomized 
ewes.  Endocrinology 1982;111:1737-1739. 
45. Gazal OS, Leshin LS, Stanko RL, Thomas MG, Keisler DH, Anderson LL and 
Williams GL.  Gonadotropin-releasing hormone secretion into third-ventricle 
cerebrospinal fluid of cattle: Correspondence with the tonic and surge release of 
luteinizing hormone and its tonic inhibition by suckling and neuropeptide Y.  Biol 
Reprod  1998;59:676-683. 
46.  Crowder ME, Giles PA, Tamanini C, Moss GE and Nett TM.  Pituitary content of 
gonadotropins and GnRH-receptors in pregnant, postpartum and steroid treated ovx 
ewes.  J Anim Sci 1982;54:1235-1242. 
 
 
 
 
  
47
APPENDIX 
Progesterone RIA 
 
Single Antibody RIA Kit, Diagnostic Products Corporation, Los Angeles, CA 
 
References: 
 Jones, E.J., Armstrong, J.D. and Harvey, R.W.  J. Anim. Sci. 69:1607- (1991) 
 Diagnostic Products Corporation Coat-A-Count Progesterone Kit, Los Angeles,  
CA 
Simpson, R.B., Armstrong, J.D. and Harvey, R.W.  J. Anim. Sci. 70:1478- 
(1992). 
 
 
1. Iodinated Product: Iodination grade hP4. 
 
2. Antibody:  Anti-human P4 coated tubes.  
 
3. Standards:  Human serum with added P4.  Range: 0.1 – 20.0 ng/ml. 
 
4. Reference:  Human standard preparation added to bovine serum. 
 
5. RIA Procedure:  
A. Begin and complete assay 
1. Pipette in non-coated polypropylene tubes 
NSB – 100 µl of 0 std  
2. Pipette in antibody coated tubes 
0 Std – 100 µl  
Std – 100 µl 
Ref – 100 µl 
Unknowns – 100 µl 
3. Pipette 1 ml of 125I-P4 provided in the kit into all tubes including two 
Total Count non-coated polypropylene tubes. 
4. Vortex tubes briefly and incubate at room temperature for 3 h. 
5. Pour off supernatant. 
6. Count radioactivity of each tube using a gamma counter. 
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Equine FSH RIA 
 
 
References:   
A.F. Parlow, NIDDK 
 Williams, G.L., Kotwica, J., Slanger, W.D., Olson, D.K., Tilton, J.E. and 
Johnson  
L.J.  J. Anim. Sci. 54:594- (1982) 
 
1. Iodinated Product: Iodination grade eFSH (AFP-5022B). 
 
2. Antibody:  Anti-equine FSH (AFP-2062096). Dilution 1:12,500. 
 
3. Standards:  Iodination grade eFSH (AFP-5022B).  Range: 0.5 – 25.0 ng/ml. 
 
4. References:  eFSH added to equine serum. 
 
5. RIA Procedure: 
A. Day 1: Begin Assay 
1. NSB – 500 µl of 1% PBS-EW (egg white). 
2. 0 Std – 500 µl of 1% PBS-EW. 
3. Stds – 200 µl std + 300 µl of 1% PBS-EW. 
4. Ref – 200 µl ref + 300 µl of 1% PBS-EW. 
5. Unknown – 200 µl sample + 300 µl of 1% PBS-EW. 
6. Pipette 200 µl of PBS-EDTA + 1:400 NRS without primary antibody 
into NSB tubes only. 
7. Pipette 200 µl of anti-eFSH (diluted in PBS-EDTA+1:400 NRS) into 
all tubes except NSB and TC tubes. 
8. Vortex tubes briefly and incubate for 1 hour at room temperature. 
9. Pipette 100 µl 125I-eFSH (20,000cpm/100 µl diluted in 0.1% PBS-
EW) to all tubes. 
10. Vortex tubes briefly and incubate for 24 h at 4ºC. 
 
B. Day 2:Add Second Antibody 
1. Keep all test tubes and reagents on ice during all procedures. 
2. Pipette 200 µl of Sheep-anti-rabbit gamma globulin (SARGG; 2nd Ab) 
diluted in PBS-EDTA without NRS into all tubes except TC tubes. 
3. Votex tubes briefly and place in refrigeratory for 48-72 h at 4ºC. 
 
C. Day 4: Take Off Assay 
1. Keep all test tubes and reagents on ice during all procedures.  
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2. Add 3.0 ml ice cold PBS (0.01 M; pH 7.0) to all tubes except TC 
tubes. 
3. Centrifuge tubes for 1 h at 4ºC at 3600 rpm. 
4. Decant supernatant. 
5. Count radioactivity of each tube using a gamma counter. 
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Equine LH RIA 
 
 
References:   
 Davis, S.L., Riechert, L.E. and Niswender, G.D. Biol. Reprod. 4:415- (1971) 
 Echternkamp, S.E., Bolt, D.J. and Hawk, H.W.  J. Anim. Sci. 42:893- (1976) 
 Golter, T.D., Reeves, J.J., O’Mary, C.C., Arimura, A. and Schally. A.V.  J. 
Anim.  
Sci. 37:123- (1973) 
 Niswender, G.D., Riechert, L.E., Midgley, A.R. and Nalbandov, A.V.   
Endocrinology 84:1166-  (1969) 
 Williams, G.L. and Ray, D.E.  J. Anim. Sci. 50:906- (1980) 
 
 
1. Iodinated Product: Iodination grade eLH (AFP-5130A). 
 
2. Antibody:  Anti-equine LH (AFP-240580). Dilution 1:120,000. 
 
3. Standards:  Iodination grade eLH (AFP-5130A).  Range: 0.1 – 20.0 ng/ml. 
 
4. References:  eLH added to equine serum. 
 
5. RIA Procedure: 
D. Day 1: Begin Assay 
1. NSB – 500 µl of 1% PBS-EW (egg white). 
2. 0 Std – 500 µl of 1% PBS-EW. 
3. Stds – 200 µl std + 300 µl of 1% PBS-EW. 
4. Ref – 200 µl ref + 300 µl of 1% PBS-EW. 
5. Unknown – 200 µl sample + 300 µl of 1% PBS-EW. 
6. Pipette 200 µl of PBS-EDTA + 1:400 NRS without primary antibody 
into NSB tubes only. 
7. Pipette 200 µl of anti-eLH (diluted in PBS-EDTA+1:400 NRS) into 
all tubes except NSB and TC tubes. 
8. Vortex tubes briefly and incubate for 1 hour at room temperature. 
9. Pipette 100 µl 125I-eLH (20,000cpm/100 µl diluted in 0.1% PBS-EW) 
to all tubes. 
10. Vortex tubes briefly and incubate for 24 h at 4ºC. 
 
E. Day 2:Add Second Antibody 
1. Keep all test tubes and reagents on ice during all procedures. 
2. Pipette 200 µl of Sheep-anti-rabbit gamma globulin (SARGG; 2nd Ab) 
diluted in PBS-EDTA without NRS into all tubes except TC tubes. 
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3. Votex tubes briefly and place in refrigeratory for 48-72 h at 4ºC. 
 
F. Day 4: Take Off Assay 
1. Keep all test tubes and reagents on ice during all procedures.  
2. Add 3.0 ml ice cold PBS (0.01 M; pH 7.0) to all tubes except TC 
tubes. 
3. Centrifuge tubes for 1 h at 4ºC at 3600 rpm. 
4. Decant supernatant. 
5. Count radioactivity of each tube using a gamma counter. 
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